Literature DB >> 17975473

Hemodynamics in the isolated cirrhotic liver.

Alexander Zipprich1.   

Abstract

Increased intrahepatic resistance is the initial event to the increased portal pressure and development portal hypertension in cirrhosis. Narrowing of the sinusoids due to anatomic changes is the main component of the increased intrahepatic resistance. However, a dynamic component is also involved in the increased vascular tone in cirrhosis. The imbalance between the hyperresponsiveness and overproduction of vasoconstrictors (mainly endothelin-1 and cyclooxygenase-derived prostaglandins) and the hyporesponsiveness and impaired production of vasodilators [mainly nitric oxide (NO)] are the mechanisms responsible of the increased vascular tone in the sinusoidal/postsinusoidal area. In contrast, the vascular resistance in the hepatic artery, which is determined in the presinusoidal area, is decreased due to increased vasodilators (NO and adenosine). This suggests different availabilities of NO in the intrahepatic circulation with preserved production in the presinusoidal area and impaired production in the sinusoidal/postsinusoidal area.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17975473     DOI: 10.1097/MCG.0b013e318150d3b5

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  8 in total

1.  Effect of underdilated transjugular intrahepatic portosystemic shunt on prognosis in patients with prior splenectomy: a propensity score-matched case-control study.

Authors:  Wei Yao; Jia-Cheng Liu; Yong-Juan Wu; Chong-Tu Yang; Shu-Guang Ju; Ying-Liang Wang; Chao-Yang Wang; Song-Jiang Huang; Yao-Wei Bai; Yang Chen; Tong-Qiang Li; Chen Zhou; Bin Xiong
Journal:  Abdom Radiol (NY)       Date:  2022-07-12

2.  Incidence of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt (TIPS) according to its severity and temporal grading classification.

Authors:  Paolo Fonio; Andrea Discalzi; Marco Calandri; Andrea Doriguzzi Breatta; Laura Bergamasco; Silvia Martini; Antonio Ottobrelli; Dorico Righi; Giovanni Gandini
Journal:  Radiol Med       Date:  2017-05-16       Impact factor: 3.469

3.  Adenosine induces loss of actin stress fibers and inhibits contraction in hepatic stellate cells via Rho inhibition.

Authors:  Muhammad A Sohail; Ardeshir Z Hashmi; Wyel Hakim; Azuma Watanabe; Alexander Zipprich; Roberto J Groszmann; Jonathan A Dranoff; Natalie J Torok; Wajahat Z Mehal
Journal:  Hepatology       Date:  2009-01       Impact factor: 17.425

4.  Hepatic arterial vasodilation is independent of portal hypertension in early stages of cirrhosis.

Authors:  Miriam Moeller; Antje Thonig; Sabine Pohl; Cristina Ripoll; Alexander Zipprich
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

5.  Serum omentin and vaspin levels in cirrhotic patients with and without portal vein thrombosis.

Authors:  Michał Kukla; Marek Waluga; Michał Żorniak; Agnieszka Berdowska; Piotr Wosiewicz; Tomasz Sawczyn; Rafał J Bułdak; Marek Ochman; Katarzyna Ziora; Tadeusz Krzemiński; Marek Hartleb
Journal:  World J Gastroenterol       Date:  2017-04-14       Impact factor: 5.742

6.  Phosphodiesterase-5 inhibitors have distinct effects on the hemodynamics of the liver.

Authors:  Leonie Halverscheid; Peter Deibert; René Schmidt; Hubert E Blum; Torsten Dunkern; Benedikt H J Pannen; Wolfgang Kreisel
Journal:  BMC Gastroenterol       Date:  2009-09-18       Impact factor: 3.067

Review 7.  The Evolution of Transjugular Intrahepatic Portosystemic Shunt: Tips.

Authors:  Fabrizio Fanelli
Journal:  ISRN Hepatol       Date:  2014-03-18

8.  Effects of a Long-Acting Formulation of Octreotide on Patients with Portal Hypertension.

Authors:  Pei-Jing Cui; Jing Yao; Yin Zhu; Zheng-Yun Zhang; Jun Yang
Journal:  Gastroenterol Res Pract       Date:  2017-08-10       Impact factor: 2.260

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.